Stocks
GlaxoSmithKline (GSK) P/E US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | 14.4 | 4.73 | 28.7 | 30.9 | 30.9 | 33.2 | ||
| Changes by years, y/y, % | -11% | -67% | +508% | +8% | 0% | +8.3% | |||
GlaxoSmithKline. P/E
GlaxoSmithKline. P/E, changes, %
GlaxoSmithKline (GSK) P/E US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| P/E | ? | 19.5 | 17.5 | 38.9 | 20.7 | 33.2 | 33.2 | |
| Changes by years, y/y, % | -38% | -35% | +44% | +70% | +173% | |||
| Changes by quarters, q/q, % | -36% | -10% | +122% | -47% | +61% | |||
